Not Yet Recruiting
A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers
NCT07143331
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +20 more
- Locations
-
- Scientia Clinical Research Sydney, New South Wales, Australia